NDC 17433-9877

ENEMEEZ Plus

Docusate Sodium And Benzocaine

ENEMEEZ Plus is a Rectal Liquid in the Human Otc Drug category. It is labeled and distributed by Enemeez Inc. Dba Summit Pharmaceuticals. The primary component is Docusate Sodium; Benzocaine.

Product ID17433-9877_8907b1f3-d239-695b-e053-2995a90aaa51
NDC17433-9877
Product TypeHuman Otc Drug
Proprietary NameENEMEEZ Plus
Generic NameDocusate Sodium And Benzocaine
Dosage FormLiquid
Route of AdministrationRECTAL
Marketing Start Date2012-06-15
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NameEnemeez Inc. DBA Summit Pharmaceuticals
Substance NameDOCUSATE SODIUM; BENZOCAINE
Active Ingredient Strength283 mg/5mL; mg/5mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 17433-9877-3

30 TUBE in 1 CONTAINER (17433-9877-3) > 5 mL in 1 TUBE (17433-9877-0)
Marketing Start Date2012-06-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17433-9877-0 [17433987700]

ENEMEEZ Plus LIQUID
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitML
Marketing Start Date2012-06-15

NDC 17433-9877-3 [17433987703]

ENEMEEZ Plus LIQUID
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitML
Marketing Start Date2012-06-15

Drug Details

Active Ingredients

IngredientStrength
DOCUSATE SODIUM283 mg/5mL

OpenFDA Data

SPL SET ID:1670ca59-7275-4ac6-bef4-674a7b24c7b3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1192986
  • 1192984

    • Trademark Results [ENEMEEZ Plus]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ENEMEEZ PLUS
    ENEMEEZ PLUS
    76145292 2750865 Live/Registered
    ENEMEEZE, INC.
    2000-10-12
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.